![](images/graphics/blank.gif)
EGFR mutations
-
Analysis of mutation and protein expression of EGFR in patients with lung adenocarcinoma; investigation the hypermethylation frequency of EGFR, BRCA1, MGMT, MLH1, RASSF1A and correlation of the methylation between these genes with mutations and protein expression of EGFR.
27p
capheviahe26
25-01-2021
20
4
Download
-
Assessed the level of mRNA expression of CIZ1b, VEGF, EGFR mutations and the rate of Merkel cell infection in patients with non-small cell lung cancer. Assessed the level of mRNA expression of CIZ1b, VEGF, EGFR mutations and the rate of Merkel cell infection in patients with non-small cell lung cancer.
32p
trinhthamhodang7
31-08-2020
35
3
Download
-
Analysis of mutation and protein expression of EGFR in patients with lung adenocarcinoma. Investigation the hypermethylation frequency of EGFR, BRCA1, MGMT, MLH1, RASSF1A and correlation of the methylation between these genes with mutations and protein expression of EGFR.
27p
trinhthamhodang7
31-08-2020
41
2
Download
-
To describe the clinical and subclinical features of lung cancer patients with EGFR mutations before TKIs therapy and in the relapsed period. To identify the T790M mutation and MET amplification in patients with lung cancer and EGFR-TKIs resistance and the relationship with clinical and subclinical features.
29p
cothumenhmong6
17-07-2020
14
2
Download
-
Epidermal growth factor receptor (EGFR)-mediated signal transduction is often hyperactivated in tumour cells and therefore considered a promising target for cancer therapy. A number of computational models have been developed which describe the pathway in great detail.
13p
media19
04-03-2013
40
3
Download
-
Controlled activation of epidermal growth factor receptor (EGFR) is sys-tematically guaranteed at the molecular level; however, aberrant activation of EGFR is frequently found in cancer. Transcription induced by EGFR activation often involves the coordinated expression of genes that positively and negatively regulate the original signaling pathway; therefore, altera-tions in EGFR kinase activity may reflect changes in gene expression asso-ciated with the pathway.
13p
vinaphone15
25-02-2013
34
5
Download
-
The function of the epidermal growth factor receptor (EGFR) is dysregu-lated in various types of malignancy as a result of gene amplification, mutations, or abnormally increased ligand production. Therefore, the tyro-sine kinase activity of the EGFR is a promising therapeutic target.
11p
mobifone23
18-01-2013
45
4
Download
-
Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành hóa học dành cho các bạn yêu hóa học tham khảo đề tài: Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer
8p
dauphong4
03-01-2012
57
6
Download
-
Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Pyrosequencing, a method approved to detect the two major EGFR mutations for anti EGFR therapy in NSCLC
7p
toshiba22
21-11-2011
83
6
Download
-
Abstract Epidermal growth factor receptor (EGFR) kinase domain mutations hyperactivate the kinase and confer kinase addiction of the non-small-cell lung cancer (NSCLC) tumor cells. Almost all of these mutations are located within exons 18-21. The -216 single nucleotide polymorphism in the promoter region is associated with increased EGFR production. We present a method for detecting these common mutations in 81 cases of NSCLC.
6p
toshiba23
18-11-2011
72
3
Download
-
Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma
10p
matuot_238
12-10-2011
42
3
Download
-
Trong vài năm qua, sự chữa trị trong oncology đã càng ngày càng đi sâu vào molocular biology. Trên thế giới, hiện nay đã bắt đầu có thuốc chống ung thư dựa theo lối này, chẳng hạn monoclonal antibodies chống lại epidermal growth factor receptor (EGFR) và vascular endothelial epidermal growth factor (VGEF). Tại HKỳ các thuốc này đang được dùng trong chiến tuyến thứ nhì hay thứ ba (second line or third line therapies) để chống ung thư đã chuyển di (metastatic colorectal carcinoma). Trong việc tạo sinh ra ung thư ruột già đã chuyển di, ở tầm...
4p
sinhtobo111
13-04-2011
38
3
Download
CHỦ ĐỀ BẠN MUỐN TÌM
![](images/graphics/blank.gif)